European Committee for Treatment & Research in Multiple Sclerosis

European Committee for Treatment & Research in Multiple Sclerosis The European Committee for Treatment & Research in Multiple Sclerosis - the world's largest organisat

SAVE THE DATE: MSMilan2023, the 9th joint ECTRIMS-ACTRIMS meeting, will be held as a hybrid event on 11–13 October in Milan, Italy

🧳Are you travelling as a group to in Barcelona?Finding multiple hotel rooms is now made easy with our booking site. Ev...
25/07/2025

🧳Are you travelling as a group to in Barcelona?

Finding multiple hotel rooms is now made easy with our booking site. Even better, you can save with the best group rates at hotels near the conference venue.

👉 Book your stay here: https://bit.ly/40Hl2t0

23/07/2025

⏳ Final week for early bird registration!

Don’t miss your chance to attend at a reduced rate. Early bird pricing ends 30 July.

Join leading experts in the field, including Dr. Mitzi Joi Williams of the Joi Life Wellness Group MS Center, who will speak at Educational Session 11 on social determinants of health and multiple sclerosis.

📅 25 September, 11:15-12:15 CEST I Barcelona, Spain and online

🔎 View the full programme: https://bit.ly/41Q8m3h

✅ Register now! https://bit.ly/4gYUuIA

Do you or a colleague have expertise in:✔️clinical research✔️aspects of MS clinical trials✔️rehabilitation✔️epidemiology...
22/07/2025

Do you or a colleague have expertise in:
✔️clinical research
✔️aspects of MS clinical trials
✔️rehabilitation
✔️epidemiology
✔️other demyelinating diseases such as NMOSD or MOGAD
✔️pediatric MS, or
✔️implementation science?

We're seeking dedicated experts to join the International Advisory Committee on Clinical Trials in MS for the 2026 term!

The Committee provides perspective and guidance in areas of interest to planning and implementation of clinical trials for new agents for the treatment of multiple sclerosis. It is well known for its work in developing the McDonald Diagnostic Criteria and the 1996 and 2013 clinical course descriptors for MS.

Read the requirements & submit a nomination ➡️ https://bit.ly/3Zr7C3b

What will the proposed 2024 McDonald Criteria mean for multiple sclerosis diagnosis worldwide?The updated criteria aim t...
21/07/2025

What will the proposed 2024 McDonald Criteria mean for multiple sclerosis diagnosis worldwide?

The updated criteria aim to help clinicians diagnose MS with greater accuracy. But how easily can these criteria be applied across diverse healthcare systems and resource settings?

📊 The MS International Federation (MSIF)'s latest Atlas of MS shows that 60% of countries report at least one obstacle to adopting the 2017 McDonald Criteria. Even high- and upper-middle-income countries cite challenges from lack of awareness to uneven access to key diagnostics.

In our new Spotlight, experts from Thailand and Chile share real-world insights:

- Prof. Sasitorn Siritho of Mahidol University and Siriraj Hospital outlines Thailand's ongoing healthcare challenges in rural areas, including limited access to MS specialists.

- Prof. Ethel Ciampi of Pontifical Catholic University of Chile highlights the country's latitudinal diversity, public/private disparities, and the need for improved neuroradiology access.

Read the article 👉 https://bit.ly/4kPn1lE

Mahidol University Pontificia Universidad Católica de Chile

18/07/2025

Meet the speakers at !

Dr. Lousin Moumdjian of Hasselt University International, Dr. Ludovico Pedullà of AISM - Associazione Italiana Sclerosi Multipla, and Dr. Barbara Seebacher of REHA Zentrum Münster will discuss music and rhythm-based rehabilitation in persons with multiple sclerosis.

Join their session in person or online:
Educational Session 7 at ECTRIMS 2025
📅 24 September, 8:30 - 9:30 CEST
📍 Barcelona International Convention Center, Spain, and online

> See our full event programme: https://bit.ly/41Q8m3h

> Register now and enjoy early bird discounts: https://bit.ly/4gYUuIA

RIMS (Rehabilitation in Multiple Sclerosis)

17/07/2025

🎧 New podcast!

Professor Jan Hillert of Karolinska Institutet in Sweden and chair of the Swedish MS Registry joins host Brett Drummond of MStranslate to discuss the expanding role of patient-reported outcomes (PROs) in multiple sclerosis research. PROs have become a critical tool for capturing the lived experience of MS, providing valuable insights into symptoms such as fatigue, mood, and cognitive changes that may evade objective measurement but have a profound impact on quality of life.

"We can assess the importance of treatments with patient report outcomes, statistically prove the importance of treatments. We can prove the importance of lifestyle. We can show the importance of socioeconomic background. We can even use patient report outcome data as predictors for what will be in five or 10 years. So even what we have today is really pretty good," says Prof. Hillert.

Learn more about how real-world impact can shape the future of MS care and treatment. Tune in now!

Spotify: https://bit.ly/3GuXb8F
Apple Podcasts: https://apple.co/4eReZY1
Website: https://bit.ly/44MwkwF

16/07/2025

Attention MS nurses!

Did you know that offers special rates for nurses? Your participation at our annual Congress is important in helping shape the future of care for people with multiple sclerosis. in Barcelona offers special sessions where MS nurses can learn about the latest advances and connect with others in the field.

Watch Joelle Massouh of Harley Street Medical Centre - Abu Dhabi explain why fellow nurses should attend.

Save on registration by signing up before the early bird rate expires on 30 July! https://bit.ly/4gYUuIA

🎓 Webcasts from our Summer School in Stockholm this June are now available on myECTRIMS! Gain insights from leading expe...
15/07/2025

🎓 Webcasts from our Summer School in Stockholm this June are now available on myECTRIMS!

Gain insights from leading experts on Visual System Evaluation in MS and Other Demyelinating Diseases. Sessions explored diagnostic tools, including optical coherence tomography, visual evoked potentials, and MRI, along with their applications, limitations, and implications in both clinical practice and research. Participants also took part in hands-on workshops on these techniques.

Watch the recordings here: https://bit.ly/3IvdjaH

13/07/2025

Got your ⛱️ summer playlist ready?

Now is the best time to catch up on recent ECTRIMS Podcast episodes. Add these insightful conversations with MS research experts to your playlist!

▶️ Biomarkers - with Professor Charlotte Teunissen of Amsterdam UMC and Associate Professor Michael Khalil of Medizinische Universität Graz https://bit.ly/4lvq1VG

▶️ Autologous haematopoietic stem cell transplantation (AHSCT) - with Dr. Joachim Burman of Uppsala universitet and Dr. Jennifer Massey of St. Vincent’s Hospital and UNSW https://bit.ly/3U3SLsa

▶️ The Tolebrutinib Trial Results - with Dr. Robert Fox of Cleveland Clinic and Dr. Jiwon Oh of University of Toronto https://bit.ly/4eJ5Roc

▶️ Diet in MS - with Dr. Brigit de Jong of Amsterdam UMC https://bit.ly/40IgoKG

Subscribe to the ECTRIMS Podcast on Spotify and Apple Podcasts to stay up to date on key research topics. And don't miss tuning in to our upcoming daily takeaways from in Barcelona in September with host Brett Drummond of MStranslate.

Do you or a colleague have expertise in:✔️clinical research✔️aspects of MS clinical trials✔️rehabilitation✔️epidemiology...
11/07/2025

Do you or a colleague have expertise in:
✔️clinical research
✔️aspects of MS clinical trials
✔️rehabilitation
✔️epidemiology
✔️other demyelinating diseases such as NMOSD or MOGAD
✔️pediatric MS, or
✔️implementation science?

We're seeking dedicated experts to join the International Advisory Committee on Clinical Trials in MS for the 2026 term!

Consider submitting a nomination. The deadline is 29 August 2025.

For details ➡️ https://bit.ly/3Zr7C3b

10/07/2025

Meet the speakers at !

Prof. Menno Schoonheim, Scientific Director at Amsterdam UMC, will join Educational Session 5 to discuss clinical progression of multiple sclerosis and the latest advancements in MRI.

Join the session in-person or online:
📅 September 24, 8:30 - 9:30 CEST
📍 Barcelona International Convention Center, Spain, and online

> See our full event programme: https://bit.ly/41Q8m3h

> Register today: https://bit.ly/4gYUuIA

Early bird registration ends 30 July!

📅 Only 1 day to go!Don’t miss our FREE webinar on the 2024 Diagnostic Criteria & Application in Varied Clinical Settings...
07/07/2025

📅 Only 1 day to go!

Don’t miss our FREE webinar on the 2024 Diagnostic Criteria & Application in Varied Clinical Settings.

🗓️ Tuesday, 8 July | 18:00–19:00 CEST

Join us for a practical and insightful session exploring how the proposed 2024 MS diagnostic criteria can be applied across diverse clinical environments.

Dr. Avinash Chandra of Annapurna Neurological Institute & Allied Sciences in Nepal will share a short clinical case highlighting the potential of the 2024 diagnostic criteria and their application in resource-limited settings.

Dr. Jaume Sastre-Garriga of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) will walk through the criteria revisions, their rationale, and potential impact on patient care.

🎓 A must-attend for clinicians and researchers looking to stay current in MS diagnosis.

🔗 Last chance to register on myECTRIMS – secure your spot here: https://bit.ly/3G0PYN4

Adresse

Basel

Telefon

+41616867777

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Committee for Treatment & Research in Multiple Sclerosis erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an European Committee for Treatment & Research in Multiple Sclerosis senden:

Verknüpfungen

Teilen

Kategorie